|
GeneData AG, founded in 1997 and headquartered in Basel, Switzerland, is a privately held firm that develops drug discovery and development technologies. Its software and services are marketed to commercial and academic pharmaceutical, agrochemical, and biotechnology organizations and researchers worldwide. The firm works with pharmaceutical partners in developing systems that streamline anti-infection, cancer, plant protection, and other drug development research. The company is known for its GeneData Expressionist (R), GeneData Phylosopher (R), and GeneData Screener (R) products. GeneData Expressionist allows users to identify and validate novel biomarkers and evaluate bioactive molecules. GeneData Phylosopher is a research information system that streamlines genomics drug discovery processes. It includes target identification, drug target validation, and assay development features. GeneData Screener supports ultra high throughput screening, high-content screening, and compound profiling processes. GeneData investors include Novartis Venture Fund, Alta Partners, Altana Pharma, Galenica, Lombard Odier Darier Hentsch, and Schweizerhall. The company's founders and employees also have invested in the firm. GeneData maintains additional offices in the United States and Germany.
|